Cat. No. 5154
Biological ActivityHumanin analog; increases glucose stimulated insulin secretion and glucose metabolism in vivo and in vitro. Also enhances glucose sensing in βTC3 cells and lowers blood glucose in Zucker diabetic fatty rats. Prevents endothelial dysfunction and delays progression of atherosclerosis in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Kuliawat et al (2013) Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell. FASEB J. 27 4890. PMID: 23995290 .
Oh et al (2011) Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice. Atherosclerosis. 219 65. PMID: 21763658.
Muzumdar et al (2009) Humanin: a novel central regulator of peripheral insulin action. PLoS One. 4 e6334. PMID: 19623253 .
If you know of a relevant reference for HNGF6A please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses HNGF6A from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: HNGF6A, supplier, Alzheimer's, disease, insulin, diabetes, β, cells, humanin, endothelial, dysfunction, atherosclerosis, humanin, analogue, HN, beta, analog, Tocris Bioscience, Insulin and Insulin-like Receptor products
Find multiple products by catalog number
New Products in this Area
Potent and selective PDGFR inhibitorGSK 1363089
Potent inhibitor of MET, VEGFR2, Ron and AXLPF 06273340
Potent and selective pan-Trk inhibitor; peripherally restricted
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.